CLINICAL_TRIALS
trial_result
· 2025-06-05
Clinical Trial Update: Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes [Phase 2]
Summary
Phase 2 trial evaluating Tauroursodeoxycholic Acid (TUDCA) in individuals with newly diagnosed Type 1 diabetes has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Robin Goland, MD | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2025-06-05